TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS).
Saved in:
| Title: | TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS). |
|---|---|
| Authors: | Berclaz, Luc M.1 (AUTHOR) anton.burkhardmeier@med.uni-muenchen.de, Altendorf-Hofmann, Annelore2 (AUTHOR), Lindner, Lars H.1 (AUTHOR), Burkhard-Meier, Anton1 (AUTHOR), Di Gioia, Dorit1 (AUTHOR), Dürr, Hans Roland3 (AUTHOR), Klein, Alexander3 (AUTHOR), Albertsmeier, Markus4 (AUTHOR), Schmidt-Hegemann, Nina-Sophie5 (AUTHOR), Klauschen, Frederick6 (AUTHOR), Knösel, Thomas6 (AUTHOR) luc.berclaz@med.uni-muenchen.de |
| Source: | Cancers. May2023, Vol. 15 Issue 10, p2735. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers15102735 |
